Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Doctor Fights Overpopulation with Nonsurgical Contraceptive

By Drug Discovery Trends Editor | May 22, 2015

Jeffrey Jensen. (Credit: OHSU)An Oregon doctor is researching a non-surgical, permanent contraceptive method for women in developing countries, with some funding from the Gates Foundation. The work is being done with an eye toward curbing overpopulation, and to improve quality of life in impoverished countries, they said.

Jeffrey Jensen, of the Oregon Health and Science University, was awarded a $5 million grant by the Bill and Melinda Gates Foundation in October – and is reportedly seeking further funding to continue his work.

The Oregon Permanent Contraception Research Center is conducting research on primates using polidocanol foam, a treatment currently approved by the FDA for treating varicose veins, according to an announcement from the school.

“My goal is very simple: to make every pregnancy planned and highly desired,” Jensen reportedly told the Portland Business Journal last week.

Though the foam is currently the primary research for permanent contraception, the center is also seeking requests for proposals for other concepts that may work in places across the globe where there are not enough resources to do surgery easily, according to an OHSU release.

An estimated 222 million women around the world would like to delay or stop having children entirely – but have no access to contraception, for a variety of economic and social reasons, according to World Health Organization statistics. The organization also estimates about 100 million women will undergo sterilization over the next two decades.

Some religious and pro-life groups have opposed the work, through blogs such as LifeSiteNews. They have linked the research to “eugenics” movements of the past.

The Gates Foundation was started with reproductive health as a major goal. However, founder Bill Gates has said that contraception – and improved survival rates for the children who are born – would lead to improved quality of life in developing countries, as he told a TED Talks conference in 2010. Through programs such as the organization’s ongoing malaria-elimination initiative, Gates and his Foundation have said that human population growth can be slowed.

“If we improve health rapidly we will get the peak population to be as much as a billion below the current expected peak. That is about 8.3 billion versus 9.3,” Gates said, at the TED conference.


Filed Under: Drug Discovery

 

Related Articles Read More >

Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
Labcorp widens precision oncology toolkit, aims to speed drug-trial enrollment
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE